Ursinus College

Kaleidoscope Performing Arts Center

Opened in the Spring of 2005, “The Kaleidoscope” was designed as a home for the Ursinus College’s new Theater and Dance Majors.

The complex supports both academic and extra-curricular programs. The 350-seat Lenfest Theater is Ursinus College’s first proscenium stage. The auditorium consists of an orchestra level and balcony with side seating boxes. The stagehouse provides the necessary width to accommodate dance as well as full counterweight rigging for all performance types. A motorized orchestra lift can create an orchestra pit or expand the stage when desired.

The flexible studio space has been provided with a wire rope grid so that lights can be safely hung anywhere in the room. A system of demountable platforms allows the studio to be set up in varied configurations. A large rehearsal room, scene and costume shops, dressing rooms, classrooms and faculty offices are provided to support the two performances spaces FDA began work with Ursinus College and Perry Dean Rogers during the programming phase. The performing arts center is the first of 3 major facilities programmed for the campus: new music and visual arts spaces are planned.

  • Client: Ursinus College
  • Architect: Perry Dean Rogers
  • Completion Year: 2005
  • Location: Collegeville, Pennsylvania
  • Acoustician: Jaffe Holden Acoustics
  • Building Size: 55,000 s.f.


Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
error: Content is protected. Please reach out to rhackman@fda-online.com for any materials needed. Thank you